InvestorsHub Logo
Post# of 251894
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 82943

Tuesday, 08/03/2010 12:18:17 PM

Tuesday, August 03, 2010 12:18:17 PM

Post# of 251894
NSCLC predictive biomarker

About 6 to 7 percent of non-small cell lung cancer patients have the rearrangement

The prevalence of the EML4-ALK fusion oncogene is higher among lung adenocarcinomas, in non or light smokers and in EGFR, KRAS-negative cases.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.